GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 89 filers reported holding GW PHARMACEUTICALS PLC in Q4 2014. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $313,000 | -30.3% | 3,215 | -12.0% | 0.06% | -34.1% |
Q2 2020 | $449,000 | +24.0% | 3,655 | -11.6% | 0.09% | -2.2% |
Q1 2020 | $362,000 | -17.0% | 4,133 | -0.8% | 0.09% | +5.9% |
Q4 2019 | $436,000 | -54.9% | 4,168 | -70.8% | 0.08% | -79.4% |
Q4 2014 | $966,000 | – | 14,278 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |